Manufacturing And Sustainability

  1. What Analytics Drive Process Intensification? 8/27/2024

    Bioprocess Online Live panelists discuss the most fundamental analytics that inform and enable process intensification strategies in this segment of Bioprocess Intensification In The Real World.

  2. What Bioprocessing Bottlenecks Does Process Intensification Address? 8/27/2024

    Supply chains, consumables, and data are identified as three of the management challenges that intensified processes and process automation technology (PAT) are addressing at AbbVie and AstraZeneca.

  3. Planning for Success: Supply Resiliency Strategies for Bench to Production 10/18/2023

    Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.

  4. Speed Up Process Development With HTS Tools For Affinity Chromatography 7/16/2024

    High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. Learn about a solution that addresses challenges with their use in new modalities.

  5. Three Novel Protein Therapeutic Worldviews 9/13/2024

    In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, we meet panelists who share their topline perspectives on developing complex, novel protein therapeutics.

  6. Animal Testing & Tox: What's Required Today? 2/21/2023

    In this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, Umoja Biopharma VP of Regulatory Affairs Heln Kim entertains audience questions on FDA toxicology and animal study requirements in light of the Reducing Animal Testing Act passed in December, 2022.

  7. IND Submissions Are On The Rise 2/21/2023

    During this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray, we asked our live audience about their near-term IND submission plans. Our panelists, NDA Partners Regulatory Affairs Expert Consultant Daniela Drago, Ph.D. and Umoja Biopharma VP of Regulatory Affairs Helen Kim, reflected on the uptick in submissions to the FDA in recent years and prognosticated on the trend.

  8. A Collaboration With Zurich University Of Applied Sciences 5/19/2025

    Explore ZHAW’s pioneering work and collaboration in cell cultivation and bioprocessing to deliver scalable, high-performance solutions that address key challenges in biomanufacturing scale-up.

  9. IND Submission Advice From The Front Lines 2/21/2023

    NDA Partners Regulatory Affairs Expert Consultant Daniela Drago, Ph.D. and Umoja Biopharma VP of Regulatory Affairs Helen Kim share parting shots and nuggets of IND submission wisdom, and respond to a few final audience questions, in this final segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray.

  10. Process Intensification Audience Q&A 8/27/2024

    Our panelists take audience questions on process intensification lessons learned from other industries.